TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday

by | Jan 14, 2026 | General

U.S. stocks were lower, with the Nasdaq Composite falling more than 200 points on Wednesday.

Shares of TG Therapeutics Inc (NASDAQ:TGTX) rose sharply during Wednesday’s session after the company reported preliminary fiscal-year 2025 total global revenue results on Tuesday after the market closed.

TG Therapeutics said preliminary total global revenue for full-year 2025 was approximately $616 million. The company reported preliminary U.S. net product revenue for BRIUMVI of approximately $182 million for the fourth quarter and $594 million for the full year. The financial figures are unaudited and subject to final closing procedures.

TG Therapeutics shares jumped 11.6% to $31.10 on Wednesday.

Here are some other big stocks recording gains in today’s session.

  • Rich Sparkle Holdings Ltd (NASDAQ:ANPA) shares jumped 13.5% to $95.31.
  • Cerus Corp (NASDAQ:CERS) gained 12.7% to $2.84.
  • Clover Health Investments Corp (NASDAQ:CLOV) jumped 11.2% to $2.82 after the company reported a year-over-year increase in Membership Growth in its Medicare Advantage PPO plans. The company expects to achieve its first-ever FY GAAP net income profitability.
  • Highpeak Energy Inc (NASDAQ:HPK) shares rose 8.3% to $5.07.
  • Array Digital Infrastructure Inc (NYSE:AD) gained 7.8% to $57.87.
  • Concentrix Corp (NASDAQ:CNXC) jumped 7.7% to $42.18. Concentrix on Tuesday reported its fourth-quarter results and issued forward guidance that weighed on investor sentiment.
  • Adient PLC (NYSE:ADNT) surged 7.5% to $23.05. Adient is scheduled to discuss first-quarter fiscal 2026 financial results on Feb. 4.
  • Kindly MD Inc (NASDAQ:NAKA) gained 7.4% to $0.50.
  • Cadeler (NYSE:CDLR) gained 7.2% to $21.92.
  • Innovative Solutions and Support Inc (NASDAQ:ISSC) rose 7.2% to $20.63.
  • Nutrien Ltd (NYSE:NTR) gained 7% to $65.62. Morgan Stanley analyst Vincent Sinisi upgraded Nutrien from Equal-Weight to Overweight and raised the price target from $70 to $77.
  • Alpha Tau Medical Ltd (NASDAQ:DRTS) gained 6.4% to $6.98.

Read This Next:

Photo via Shutterstock